GENERATIVE AI & MACHINE LEARNING TO HELP HEALTH CARE PROVIDERS EXPEDITE CLINICAL AND OPERATIONAL WORKFLOWS : GE HealthCare looks to unlock patient care opportunities in unused data estimated in Deloitte report
People In Health Care
Amit Yadav, CEO GE HealthCare Australia & New Zealand
Filmed Sydney, New South Wales | October 2024
Amit Yadav holds the position of CEO at GE HealthCare in Australia and New Zealand, where he oversees a team of 450 skilled professionals focused on delivering healthcare solutions, particularly in the areas of diagnostic imaging, monitoring, and ultrasound. Talking with Australian Health Journal, Amit has background as a clinical radiographer, evolving into roles at GE, where he gained expertise as a CT trainer and later commercial responsibilities.
Drawing from GE’s 125-year legacy in healthcare, Amit is leading efforts to integrate AI into medical imaging devices and optimise workflow efficiencies. He stresses the importance of leveraging the vast amount of untapped healthcare data, with an emphasis on automating manual processes to enhance productivity. Additionally, his focus extends to utilising AI for workflow optimisation and ensuring compliance with local regulations and standards to prioritise safety.
Amit places significant emphasis on educating healthcare professionals about the capabilities and limitations of AI and digital solutions. Collaborating with partners such as Amazon Web Services (AWS), he aims to implement user-friendly enterprise-wide solutions that cater to the needs of clinicians. Amit also recognises the necessity of continuous education and training programs for healthcare professionals, working closely with colleges and universities to integrate AI and digital education at various levels.
Furthermore, Amit is actively involved in fostering partnerships with educational institutions to develop training and education programs for the next generation of healthcare leaders. He emphasises the need for a comprehensive understanding of AI’s implications in patient treatment and advocates for personalised approaches to healthcare outcomes. Amit’s commitment to advancing healthcare through innovation and education underscores GE HealthCare’s dedication to driving positive change in the industry.
You Might also like
-
Patient family develops app for improved adherence and clinical outcomes
Darron Goralsky, a physiotherapist with over 30 years of experience, is the Clinical Director and Founder of Melbourne TMJ and Facial Pain Centre. He leads a multidisciplinary team dedicated to treating jaw pain, facial pain, and headaches. Goralsky has observed a rise in musculoskeletal issues among younger populations, largely due to increased screen time and poor posture, trends that intensified during the COVID-19 pandemic. Emphasising technology integration and patient responsibility, he believes digital health solutions play a crucial role in improving adherence and outcomes for both patients and caregivers.
-
Landmark brain shape study
For over a century, researchers have thought that the patterns of brain activity that define our experiences, hopes and dreams are determined by how different brain regions communicate with each other through a complex web of trillions of cellular connections.
Now, a Monash University Turner Institute for Brain and Mental Health-led study has examined more than 10,000 different maps of human brain activity and found that the overall shape of a person’s brain exerts a far greater influence on how we think, feel and behave than its intricate neuronal connectivity.
-
Report gives insights to clinical trial activity in Australia
Established in 2024, Bellberry is a Adelaide-based national, not-for-profit organisation that provides streamlined scientific and ethical reviews of human research. It is the 2025 winner of the Championing Health Award in the Telstra Best of Business Awards.
Australian Health Journal spoke with Bellberry Limited CEO, Kylie Sproston on the organisation and the findings in activity documented in the Clinical Trial Activity Report (CTAR) 2024.